tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine

C215H344N10O54S3 — CID 158200284

IUPACtris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine
SMILESCC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCC/N=C(\N)N=Cc1ccccn1.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCC/N=C(\N)NCCC1CCCCC1C.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCCN/C(N)=N/CC(C)(C)C
InChIInChI=1S/C38H71N3O9.3C36H50O9S.C35H58N4O9.C34H65N3O9/c1-3-29(42)22-30(43)12-6-16-34(47)25-37(50)26-35(48)17-8-15-32(45)23-31(44)13-7-14-33(46)24-36(49)18-9-20-40-38(39)41-21-19-28-11-5-4-10-27(28)2;3*1-28(24-20-16-12-11-13-17-21-25-29(2)36(40)41)35(39)31(4)33(38)26-22-18-14-9-7-6-8-10-15-19-23-27-34(30(3)32(5)37)45-46(42,43)44;1-2-26(40)19-27(41)10-5-14-31(45)22-34(48)23-32(46)15-7-13-29(43)20-28(42)11-6-12-30(44)21-33(47)16-8-18-38-35(36)39-24-25-9-3-4-17-37-25;1-5-24(38)18-25(39)10-6-14-29(43)21-32(46)22-30(44)15-8-13-27(41)19-26(40)11-7-12-28(42)20-31(45)16-9-17-36-33(35)37-23-34(2,3)4/h6-8,12-13,17,27-37,42-50H,3-5,9-11,14-16,18-26H2,1-2H3,(H3,39,40,41);3*6-11,13-15,17-26,28,30-31,33-35,38-39H,12,16,27H2,1-5H3,(H,40,41)(H,42,43,44);3-7,9-11,15,17,24,26-34,40-48H,2,8,12-14,16,18-23H2,1H3,(H2,36,38);6-8,10-11,15,24-32,38-46H,5,9,12-14,16-23H2,1-4H3,(H3,35,36,37)/b12-6+,13-7+,17-8+;3*8-6+,9-7+,13-11+,15-10+,18-14+,21-17+,23-19+,24-20+,26-22+,29-25+;10-5+,11-6+,15-7+,39-24?;10-6+,11-7+,15-8+
InChIKeyGAVPCIIXKUTVJK-POODESNCSA-N
MW4029.33 g/mol
LogP24.34
Rot. Bonds143

About tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine

tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine (PubChem CID 158200284) has the molecular formula C215H344N10O54S3 and a molecular weight of 4029.33 g/mol. Its IUPAC name is tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine.

Molecular Properties

Compound Nametris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine
PubChem CID158200284
Molecular FormulaC215H344N10O54S3
Molecular Weight4029.33 g/mol
Exact Mass4026.36
IUPAC Nametris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine
SMILESCC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCC/N=C(\N)N=Cc1ccccn1.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCC/N=C(\N)NCCC1CCCCC1C.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCCN/C(N)=N/CC(C)(C)C
InChIInChI=1S/C38H71N3O9.3C36H50O9S.C35H58N4O9.C34H65N3O9/c1-3-29(42)22-30(43)12-6-16-34(47)25-37(50)26-35(48)17-8-15-32(45)23-31(44)13-7-14-33(46)24-36(49)18-9-20-40-38(39)41-21-19-28-11-5-4-10-27(28)2;3*1-28(24-20-16-12-11-13-17-21-25-29(2)36(40)41)35(39)31(4)33(38)26-22-18-14-9-7-6-8-10-15-19-23-27-34(30(3)32(5)37)45-46(42,43)44;1-2-26(40)19-27(41)10-5-14-31(45)22-34(48)23-32(46)15-7-13-29(43)20-28(42)11-6-12-30(44)21-33(47)16-8-18-38-35(36)39-24-25-9-3-4-17-37-25;1-5-24(38)18-25(39)10-6-14-29(43)21-32(46)22-30(44)15-8-13-27(41)19-26(40)11-7-12-28(42)20-31(45)16-9-17-36-33(35)37-23-34(2,3)4/h6-8,12-13,17,27-37,42-50H,3-5,9-11,14-16,18-26H2,1-2H3,(H3,39,40,41);3*6-11,13-15,17-26,28,30-31,33-35,38-39H,12,16,27H2,1-5H3,(H,40,41)(H,42,43,44);3-7,9-11,15,17,24,26-34,40-48H,2,8,12-14,16,18-23H2,1H3,(H2,36,38);6-8,10-11,15,24-32,38-46H,5,9,12-14,16-23H2,1-4H3,(H3,35,36,37)/b12-6+,13-7+,17-8+;3*8-6+,9-7+,13-11+,15-10+,18-14+,21-17+,23-19+,24-20+,26-22+,29-25+;10-5+,11-6+,15-7+,39-24?;10-6+,11-7+,15-8+
InChIKeyGAVPCIIXKUTVJK-POODESNCSA-N
XLogP24.34
TPSA1185.95 Ų
H-Bond Donors44
H-Bond Acceptors52
Rotatable Bonds143
Heavy Atoms282
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004029.33
LogP ≤ 524.34
H-Bond Donors ≤ 544
H-Bond Acceptors ≤ 1052

Analyze tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine?
The IUPAC name of tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine (CID 158200284) is tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine.
What is the SMILES notation for tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine?
The canonical SMILES for tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine is CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CC(=O)C(C)C(C/C=C/C=C/C=C/C=C/C=C/C=C/C(O)C(C)C(O)C(C)/C=C/CC/C=C/C=C/C=C(\C)C(=O)O)OS(=O)(=O)O.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCC/N=C(\N)N=Cc1ccccn1.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCC/N=C(\N)NCCC1CCCCC1C.CCC(O)CC(O)/C=C/CC(O)CC(O)CC(O)/C=C/CC(O)CC(O)/C=C/CC(O)CC(O)CCCN/C(N)=N/CC(C)(C)C.
What is the InChIKey of tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine?
The InChIKey is GAVPCIIXKUTVJK-POODESNCSA-N. The full InChI is InChI=1S/C38H71N3O9.3C36H50O9S.C35H58N4O9.C34H65N3O9/c1-3-29(42)22-30(43)12-6-16-34(47)25-37(50)26-35(48)17-8-15-32(45)23-31(44)13-7-14-33(46)24-36(49)18-9-20-40-38(39)41-21-19-28-11-5-4-10-27(28)2;3*1-28(24-20-16-12-11-13-17-21-25-29(2)36(40)41)35(39)31(4)33(38)26-22-18-14-9-7-6-8-10-15-19-23-27-34(30(3)32(5)37)45-46(42,43)44;1-2-26(40)19-27(41)10-5-14-31(45)22-34(48)23-32(46)15-7-13-29(43)20-28(42)11-6-12-30(44)21-33(47)16-8-18-38-35(36)39-24-25-9-3-4-17-37-25;1-5-24(38)18-25(39)10-6-14-29(43)21-32(46)22-30(44)15-8-13-27(41)19-26(40)11-7-12-28(42)20-31(45)16-9-17-36-33(35)37-23-34(2,3)4/h6-8,12-13,17,27-37,42-50H,3-5,9-11,14-16,18-26H2,1-2H3,(H3,39,40,41);3*6-11,13-15,17-26,28,30-31,33-35,38-39H,12,16,27H2,1-5H3,(H,40,41)(H,42,43,44);3-7,9-11,15,17,24,26-34,40-48H,2,8,12-14,16,18-23H2,1H3,(H2,36,38);6-8,10-11,15,24-32,38-46H,5,9,12-14,16-23H2,1-4H3,(H3,35,36,37)/b12-6+,13-7+,17-8+;3*8-6+,9-7+,13-11+,15-10+,18-14+,21-17+,23-19+,24-20+,26-22+,29-25+;10-5+,11-6+,15-7+,39-24?;10-6+,11-7+,15-8+.
What are the key properties of tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine?
tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine has a molecular weight of 4029.33 g/mol, XLogP of 24.34, 143 rotatable bonds, 44 hydrogen bond donors, and 52 hydrogen bond acceptors.
Where does this data come from?
All data for tris((2E,4E,6E,10E,16E,18E,20E,22E,24E,26E)-13,15-dihydroxy-2,12,14,30-tetramethyl-31-oxo-29-sulfooxydotriaconta-2,4,6,10,16,18,20,22,24,26-decaenoic acid);2-(2,2-dimethylpropyl)-1-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;1-[2-(2-methylcyclohexyl)ethyl]-2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]guanidine;2-[(8E,14E,22E)-4,6,10,12,16,18,20,24,26-nonahydroxyoctacosa-8,14,22-trienyl]-1-(pyridin-2-ylmethylidene)guanidine is sourced from PubChem (CID 158200284), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).